Acurion's OncoGaze™ technology delivers critical genomic insights at the biopsy stage, empowering oncologists to make precision therapy a reality for more patients.
Investors 1
Mentions in press and media 3
| Date | Title | Description |
| 03.04.2026 | Acurion Closes $4.3M Seed Funding Round | Acurion, a San Diego, CA-based precision oncology technology company, closed its $4.3m seed financing round.
The round was led by TK & Partners, with participation from Mesa Verde Venture Partners, The National Foundation for Cancer Res... |
| 02.04.2026 | Acurion Completes $4.3M Seed Round |
SAN DIEGO, CA, Acurion announced the closing of its oversubscribed seed financing round, raising $4.3 million against a $4 million target.
>> Click here for more funding data on Acurion
>> To export Acurion funding data to PDF ... |
| - | Acurion | “Acurion's OncoGaze™ technology delivers critical genomic insights at the biopsy stage, empowering oncologists to make precision therapy a reality for more patients.” |
Reviews 0
